BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18644360)

  • 1. Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease.
    Lin MS; Li HY; Wei JN; Lin CH; Smith DJ; Vainio J; Shih SR; Chen YH; Lin LC; Kao HL; Chuang LM; Chen MF
    Clin Biochem; 2008 Nov; 41(16-17):1362-7. PubMed ID: 18644360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular adhesion protein-1, a novel molecule, in kidney and heart allograft recipients.
    Koc-Zorawska E; Przybylowski P; Malyszko JS; Mysliwiec M; Malyszko J
    Transplant Proc; 2013 Jun; 45(5):2009-12. PubMed ID: 23769096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum vascular adhesion protein-1 level predicts risk of incident cancers in subjects with type II diabetes.
    Yu TY; Li HY; Jiang YD; Chang TJ; Wei JN; Lin CM; Chu CC; Chuang LM
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1366-73. PubMed ID: 24781952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in vascular adhesion protein-1 and metabolic phenotypes after vertical banded gastroplasty for morbid obesity.
    Li HY; Lee WJ; Chen MJ; Chuang LM
    Obes Res; 2005 May; 13(5):855-61. PubMed ID: 15919838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects.
    Li HY; Lin MS; Wei JN; Hung CS; Chiang FT; Lin CH; Hsu HC; Su CY; Wu MY; Smith DJ; Vainio J; Chen MF; Chuang LM
    Clin Chim Acta; 2009 May; 403(1-2):97-101. PubMed ID: 19361461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes.
    Li HY; Lin HA; Nien FJ; Wu VC; Jiang YD; Chang TJ; Kao HL; Lin MS; Wei JN; Lin CH; Shih SR; Hung CS; Chuang LM
    PLoS One; 2016; 11(2):e0147981. PubMed ID: 26845338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney allograft recipients.
    Koc-Zorawska E; Malyszko J; Malyszko JS; Mysliwiec M
    Kidney Blood Press Res; 2012; 36(1):242-7. PubMed ID: 23154672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease.
    Stinghen AE; Gonçalves SM; Martines EG; Nakao LS; Riella MC; Aita CA; Pecoits-Filho R
    Nephron Clin Pract; 2009; 111(2):c117-26. PubMed ID: 19147993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vascular adhesion protein-1 level is higher in smokers than non-smokers.
    Wang YC; Li HY; Wei JN; Lin MS; Shih SR; Hua CH; Smith DJ; Vanio J; Chuang LM
    Ann Hum Biol; 2013; 40(5):413-8. PubMed ID: 23802578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study.
    Leoncini G; Viazzi F; Rosei EA; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Deferrari G; Pontremoli R
    J Hypertens; 2010 Jan; 28(1):156-62. PubMed ID: 19915481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients.
    Madej A; Reich A; Orda A; Szepietowski JC
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):72-8. PubMed ID: 17207171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic kidney disease in a middle and old-aged population of Beijing.
    Li ZY; Xu GB; Xia TA; Wang HY
    Clin Chim Acta; 2006 Apr; 366(1-2):209-15. PubMed ID: 16325790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.
    Coresh J; Byrd-Holt D; Astor BC; Briggs JP; Eggers PW; Lacher DA; Hostetter TH
    J Am Soc Nephrol; 2005 Jan; 16(1):180-8. PubMed ID: 15563563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
    Guebre-Egziabher F; Bernhard J; Funahashi T; Hadj-Aissa A; Fouque D
    Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
    Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
    Coresh J; Astor BC; Greene T; Eknoyan G; Levey AS
    Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.